Navigation Links
Genomic profiling of lung tumors helps doctors choose most effective treatment
Date:9/28/2007

genes that were not expressed in tumors that were resistant to cisplatin, said senior author Anil Potti, M.D., an oncologist at Duke and a researcher in the IGSP. The reverse was true, as well; genes that were not expressed in tumors resistant to cisplatin seemed to be turned on in tumors that were sensitive to it.

The important second part of this project was to come up with a therapy option for the tumors that werent sensitive, Potti said.

Its one thing for a doctor to tell a patient that he wont respond to cisplatin, he said, but we have to know what to do when he asks what do you have for me"

The researchers then examined several common second-line therapies, such as a drug called pemetrexed which uses a different mechanism of action to attack NSCLC tumors.

We found the strongest inverse correlation between tumors that were sensitive to cisplatin and those that were sensitive to pemetrexed, Potti said. This suggests that some patients who are not likely to respond to cisplatin should perhaps be treated with pemetrexed first.

A clinical trial -- the first of its kind in lung cancer -- based on the findings of genomics studies is currently underway at Duke. These are not experimental drugs, we know they work, Potti said. Its just a matter of giving each patient the right one on the first try.

Almost 180,000 people are diagnosed with lung cancer each year in the United States, and about 160,000 patients die from the disease yearly, according to the American Cancer Society. Non-small cell lung cancer is the most common form of the disease -- accounting for 80 percent of all cases.

Almost half of NSCLC patients are found to have stage four disease, meaning the cancer has spread beyond the lung into other areas of the body. Currently, only 15 to 30 percent of people treated for stage four lung cancer will be alive a year later and only two percent are alive after five years, making this the deadliest
'/>"/>

Contact: Lauren Shaftel Williams
lauren.shaftel@duke.edu
919-684-4966
Duke University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Upcoming Hemogenomics Centre in Bangalore
2. Evoprinter, a multigenomic comparative tool for rapid identification of functionally important DNA
3. International Conference On Malaria - Laveran To Genomics
4. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
5. Nutrigenomics here comes a team to better your future!
6. Genomic tests for better cancer treatment
7. Web-Based Genomics Tool Designed to Help Predict Disease Susceptibility
8. AutoGenomics Addresses TB Crisis With a Genetic Drug Resistance Test
9. Pharmacogenomic Market Gaining Greater Acceptance Across Europe
10. Nutrient Profiling System Launched By Food Officials in UK
11. Proteomic Profiling Can Detect Preterm Birth Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... July 14, 2014 This report ... market in Americas. The analysis includes market size ... period and key company share data by revenue ... Brazil and Mexico. It uses data and information ... and in-house analysis. , Scope, ...
(Date:7/14/2014)... Along with improving vision, cataract surgery may slow mental ... of dementia, a new study suggests. Better eyesight ... "These preliminary results indicate that improved vision can ... and their loved ones, both visual and non-visual," said ... University Hospitals Case Medical Center, in Ohio. Cataract ...
(Date:7/14/2014)... Kathleen Doheny HealthDay Reporter ... a spouse may be linked to multiple health issues, but ... For certain seniors, widowhood may even delay dementia, the ... problem, losing the spouse was associated with a later age ... said study researcher Dr. Bryan Woodruff. Woodruff, an ...
(Date:7/14/2014)... 2014 T.E.N., an information technology ... today that nominations will be accepted now through ... Executive® (ISE®) North America Awards. , Awards ... which recognizes executives who have made a positive ... protection, regulatory compliance, privacy and information security; and ...
(Date:7/14/2014)... 14, 2014 July 14, 2014 ... in enterprise-class cloud management, governance, and compliance software ... AvePoint software will be available to customers of ... , The hosting and value-added reseller ... following AvePoint solutions to new or existing customers: ...
Breaking Medicine News(10 mins):Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 2Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 3Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 4Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 3Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 2Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 3Health News:AvePoint Works with Rackspace to Extend Vital Management Features to Hybrid SharePoint Deployments 2Health News:AvePoint Works with Rackspace to Extend Vital Management Features to Hybrid SharePoint Deployments 3
... Guru Mashable.com Cites Organizations Using Social Media for Public Good ... The Oral Cancer Foundation was recently praised by a ... organizations that are effectively using Internet-based social media for the ... on Web 2.0 and social media such as blogs, Facebook, ...
... Counseling patients with non-alcoholic fatty liver disease (NAFLD) on how ... independent of changes in weight. These findings are in a ... a journal published by John Wiley & Sons on behalf ... (AASLD). The article is also available online at Wiley Interscience ...
... the bills were part of the Governor,s ,Prescription for Pennsylvania, ... Governor Edward G. Rendell today ceremonially signed three health care measures ... reform plan and a fourth that was originally proposed as part ... , "I,d like to recognize the good work of the ...
... ... websites inviting vivid personal stories about Internet dating and end-of-life dilemmas. Some stories will be ... director Robert Kenner. , ... (PRWEB) July 1, 2009 -- Kayce Freed Jennings, the wife of late ABC newsman Peter Jennings, ...
... herpes virus can cause inflammation, transplant rejection, study finds ... with herpes simplex virus who need a corneal transplant, ... outcomes, U.S. researchers say. , The cornea, which covers ... for vision, can be damaged when herpes simplex virus ...
... proposals and offer comment , , HARRISBURG, Pa., July ... on the Community Health Reinvestment Activities, also known and CHR, ... CHR plans are submitted to the Insurance Department by way ... known as Act 62 of 2008. , , ...
Cached Medicine News:Health News:Oral Cancer Foundation Praised for Its Social Media Efforts 2Health News:Exercise helps patients with non-alcoholic fatty liver disease 2Health News:Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs, Improve Access and Quality 2Health News:Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs, Improve Access and Quality 3Health News:Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs, Improve Access and Quality 4Health News:Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs, Improve Access and Quality 5Health News:First-Person Stories Gathered on Web Shape New Nonfiction TV Series from Veteran Producers 2Health News:First-Person Stories Gathered on Web Shape New Nonfiction TV Series from Veteran Producers 3Health News:First-Person Stories Gathered on Web Shape New Nonfiction TV Series from Veteran Producers 4Health News:Test Before Corneal Transplant May Improve Outcome 2Health News:Insurance Department Seeks Comment On Community Health Reinvestment Activities 2
(Date:7/14/2014)... 2014  Mylan Inc. (NASDAQ: MYL ) today ... Abbott (NYSE: ABT ) ... developed markets specialty and branded generics business ("the Assets") in ... will receive 105 million shares of the combined company worth ... on Friday, July 11, 2014, representing an approximately 21% ownership ...
(Date:7/11/2014)... CHAPEL HILL, N.C. , July 11, 2014 ... component of pharmaceutical marketing and, consequently, organizations are ... specifically for patients. As part of ... learned it,s important to educate, communicate and engage ... from disease awareness to patient empowerment. By mapping ...
(Date:7/11/2014)... July 11, 2014 Research and Markets ... Needles Market 2014-2018" report to their offering. ... hypodermic needle is a hollow needle commonly used with ... or to extract fluids from it. A hypodermic needle ... inject substances that cannot be ingested. Hypodermic needles are ...
Breaking Medicine Technology:Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 2Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 3Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 4Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 5Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 6Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 7Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 8Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 9Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 10Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 11New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3
... Md., May 24, 2007 /PRNewswire-FirstCall/ -- Iomai,Corporation today ... 1 trial of its patch-based needle-free influenza vaccine,before ... live,webcast will be held at 8:30 a.m. Eastern ... Details , To access the live conference call ...
... Texas--(BUSINESS WIRE)--May 29, 2007 - Introgen,Therapeutics, Inc. ... updated Phase 2 clinical trial results,for its ... upcoming,annual meetings of The American Society of ... Society of Gene Therapy (ASGT) in,Seattle., "We ...
Cached Medicine Technology:Iomai to Announce Results From Phase 1 Influenza Trial and Host,Webcast Tomorrow 2Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 2Introgen and Clinical Collaborators to Report New Results with,Advanced-Stage Cancer Therapies at Upcoming Medical Meetings 3
Disposable Microscissors: Horizontal, Curved...
Disposable Microscissors: Horizontal, Straight...
Disposable Microscissors: Vertical, 90...
Low profile, sharp-tipped scissors with a vertical cutting action. Excellent for peeling and cutting fine epiretinal membranes....
Medicine Products: